Bio-Techne Corp (NASDAQ:TECH) is reporting fourth quarter financial results on Tuesday 4th August 2020, before market open.
According to analysts surveyed by Thomson Reuters, TECH is expected to report 4Q20 income of $ 0.75 per share from revenue of $ 163.91 million.
For the full year, analysts anticipate top line of $ 726.76 million, while looking forward to income of $ 4.29 per share bottom line.
Previous Quarter Performance
Bio-Techne Corp outlined income for the third quarter of $ 1.39 per share, from the revenue of $ 194.68 million. The quarterly earnings escalated 14.88 percent compared with the same quarter last year. Wall street analysts are predicting, TECH to report 3Q20 income of $ 1.16 per share from revenue of $ 189.07 million. The bottom line results beat street analysts by $ 0.23 or 19.83 percent, at the same time, top line results outshined analysts by $ 5.61 million or 2.97 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Bio-Techne Corp
Stock Performance
According to the previous trading day, closing price of TECH was $ 278.87, representing a 79.72 % increase from the 52 week low of $ 155.17 and a 2.72 % decrease over the 52 week high of $ 286.68.
The company has a market capital of $ 10.80 billion and is part of the Healthcare sector and Biotechnology industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”TECH” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Recent Analyst recommendations
- On 15th July 2020, downgraded by Stephens to Equal-Weight from Overweight rating, with $ 273.00 target price.
- On 18th June 2020, maintained by Citigroup at Neutral rating, with $ 260.00 target price.
Recent Stock Dividend Announcement
The board of directors has authorized quarterly dividend of $ 0.32 per share on April 30, 2020. The dividend were payable on May 22, 2020 to holders of record as of the close of business on May 11, 2020 and ex-dividend date on May 8, 2020.
Conference Call
Bio-Techne Corp will be hosting a conference call at 9:00 AM eastern time on 4th August 2020, to discuss its 4Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.bio-techne.com
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells biotechnology reagents, instruments, and clinical diagnostic controls worldwide. It operates in three segments: Biotechnology, Protein Platforms, and Diagnostics. The Biotechnology segment offers specialized proteins, such as cytokines and growth factors, immunoassays, antibodies, and related reagents to the biotechnology research community; and in situ hybridization, media, and other cell culture products and reagents.
